Ultra-low dose rituximab as add-on therapy in anti-MDA5-positive patients with polymyositis /dermatomyositis associated ILD
Mengmeng Mao, Shu Xia, Bingpeng Guo, Weiping Qian, Ze-xuan Zheng, Xiaomin Peng, Rongchang Chen, Qun Luo, Qian Han
Topics & Concepts
MedicineInternal medicineDermatomyositisRituximabGastroenterologyInterstitial lung diseasePolymyositisCyclophosphamideAdverse effectSurgeryImmunologyChemotherapyLungLymphomaInflammatory Myopathies and DermatomyositisSystemic Sclerosis and Related DiseasesParkinson's Disease and Spinal Disorders